VitaNova Life Sciences Corporation has filed an 8-K report with the SEC, disclosing the resignation of Ruiming Zhou from her position as a director, effective March 12, 2026. The company clarified that Zhou's departure was not due to any disagreements regarding the company's operations, policies, or practices. This administrative update is part of the company's ongoing compliance with SEC regulations, ensuring transparency in its governance structure. The filing does not indicate any immediate impact on the company's operations or strategic direction, as it appears to be a routine change in leadership. The company continues to operate under its established governance framework, and no further details regarding the appointment of a new director have been provided at this time. Investors and stakeholders are encouraged to monitor future filings for updates on leadership changes and their potential implications for the company's strategic initiatives.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.